Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2003
12/03/2003EP0765393B1 Dna molecules which code for a plastid 2-oxoglutarate/malate translocator
12/03/2003EP0687295B1 Human b-lymphoblastoid cell line secreting anti-ganglioside antibody
12/03/2003EP0631629B1 Fungus-responsive chimaeric gene
12/03/2003CN1460025A Immunomodulatory human MHC class Ôàí antigen-binding polypeptides
12/03/2003CN1460023A Polymer-modified bioactive sythetic chemokines, and method for their mfg. and use
12/03/2003CN1459634A Method of determining immunology
12/03/2003CN1459506A Recombination expression and application of Chinese prawn antibacterial peptide gene
12/03/2003CN1129796C Medicine box for detecting hepatitis virus C and use thereof
12/02/2003US6657055 Detection of modulators of immune response; obtain cell sample, incubate with fusion proteins, monitor cells for immune response
12/02/2003US6657048 Individualized anti-cancer antibodies
12/02/2003US6657047 Nucleotide sequences coding polypeptide for use in the treatment of tumors, inflammation, psoriasis, rheumatoid arthritis, cardiovascular and vision disorders
12/02/2003US6656938 Inducing cytokine biosynthesis in animals, for the treatment of diseases, including viral and neoplastic diseases
12/02/2003US6656905 Cyclic tetrapeptide compound and use thereof
12/02/2003US6656746 Nuclelotide sequences coding enzyme inhibitor for use in the treatment of blood sisorders
12/02/2003US6656743 Human choline acetyltransferase
12/02/2003US6656717 Cyclic AMP phosphodiesterase isoforms and methods of use
12/02/2003US6656713 Compounds and methods for modulating activation of NF-κB
12/02/2003US6656708 Splice variant; expression vectors
12/02/2003US6656707 Nucleic acid molecules encoding the same; vectors, host cells, pharmaceutical compositions, selective binding agents and methods for production; antagonists and agonists; bactericides; viricides
12/02/2003US6656705 Sciellin and uses thereof
12/02/2003US6656704 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
12/02/2003US6656681 Polycystic kidney disease 12 gene and uses thereof
12/02/2003US6656679 Heat shock protein-based vaccines and immunotherapies
12/02/2003US6656467 Genetic engineering; administering immunoglobulins
12/02/2003CA2172165C Human receptor h4-1bb
12/02/2003CA2099268C Fusions of a viral protein and a destructive enzyme
12/02/2003CA2085308C Dibasic endoprotease fused to endoplasmic reticulum retention signal and use thereof
12/02/2003CA2051562C Bacillus thuringiensis isolates active against dipteran pests
12/02/2003CA2046904C Cd4 specific recombinant antibody
11/2003
11/27/2003WO2003097871A2 Marker molecules associated with lung tumors
11/27/2003WO2003097849A1 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
11/27/2003WO2003097846A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/27/2003WO2003097845A1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
11/27/2003WO2003097844A1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
11/27/2003WO2003097840A1 Engineered yeast cells for producing recombinant proteins
11/27/2003WO2003097834A2 A method for in vitro molecular evolution of protein function
11/27/2003WO2003097829A1 Process for producing protein in cell-free protein synthesis system using thioredoxin fused protein expression vector
11/27/2003WO2003097814A2 Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins
11/27/2003WO2003097812A2 Transgenic ungulates capable of human antibody production
11/27/2003WO2003097811A2 Cellular gene targets for controlling cell growth
11/27/2003WO2003097686A1 Novel protein, its dna and use thereof
11/27/2003WO2003096986A2 Compositions and methods for treatment of wounds
11/27/2003WO2003096969A2 Novel lambda phage display system and the process
11/27/2003WO2003076469A3 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature
11/27/2003WO2003075841A3 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
11/27/2003WO2003073980A3 Recombinant protein c variants
11/27/2003WO2003070765A3 Growth hormone fusion protein
11/27/2003WO2003070756A3 Novel glycopeptide antibiotics and method for synthesis thereof
11/27/2003WO2003068940A3 Complexes and methods of using same
11/27/2003WO2003068802A3 Materials and methods for preparing dimeric growth factors
11/27/2003WO2003066661A3 Human dr4 antibodies and uses thereof
11/27/2003WO2003064622A3 Aggrecanase molecules
11/27/2003WO2003062270A3 Fluorescent protein from aequorea coerulscens and uses therof
11/27/2003WO2003057897A3 Recombinant protein expression
11/27/2003WO2003056020A3 Expression vectors and promoters for heterologous gene expression
11/27/2003WO2003046150A3 Glycoprotein remodeling using endoglycanases
11/27/2003WO2003044214A3 Methods and compositions in checkpoint signaling
11/27/2003WO2003043986A3 Polypeptides of moraxella (branhamella) catarrhalis
11/27/2003WO2003042344A3 Apo2 ligand/trail formulations
11/27/2003WO2003042249A3 Peptide purification by means of metal ion affinity chromatography
11/27/2003WO2003037932A3 Human coagulation factor vii polypeptides
11/27/2003WO2003036255A3 Method for formulating a glucose oxidase enzyme with a desired property or properties and a glucose oxidase enzyme with the desired property
11/27/2003WO2003035696A3 Humanized antibodies against icam-1, their production and uses
11/27/2003WO2003034275A3 Chimeric glycosylphosphatidylinositol containing peptides
11/27/2003WO2003031578A3 Mammalian c-type lectins
11/27/2003WO2003029464A3 Genes associated with mast cell activation
11/27/2003WO2003029463A3 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
11/27/2003WO2003027147A3 Human coagulation factor vii polypeptides
11/27/2003WO2003024482B1 Crustaceans as production systems for therapeutic proteins
11/27/2003WO2003022868A3 Metal binding proteins and associated methods
11/27/2003WO2003020957A3 Use of fructose-1,6-bisphosphate aldolase for identifying novel substances having a fungicidal action
11/27/2003WO2003020759A3 A caspase- 8 binding protein, its preparation and use
11/27/2003WO2003019137A3 Methods for screening antibody-producing cells on heterogenous antigen substrates
11/27/2003WO2003018636A3 Chimaeric peptides of insulin, their compositions and use in treating diabetes
11/27/2003WO2003015717A3 Tyrosine kinase inhibitors
11/27/2003WO2003010200A3 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
11/27/2003WO2003009817A3 Stable lyophilized pharmaceutical formulation of igg antibodies
11/27/2003WO2003007881A3 Antibodies specific for nanotubes and related methods and compositions
11/27/2003WO2002103008A3 Templated molecules and methods for using such molecules
11/27/2003WO2002097075B1 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
11/27/2003WO2002094881A3 Monoclonal antibody neutralising cathepsin b activity and uses thereof
11/27/2003WO2002092801A3 Methods and compositions for making emamectin
11/27/2003WO2002092771A3 Specific binding proteins and uses thereof
11/27/2003WO2002092004A8 Use of hmg fragment as anti-inflammatory agents
11/27/2003WO2002086156A3 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
11/27/2003WO2002086113A3 Enzyme and snp marker for disease
11/27/2003WO2002085940A3 New polynucleotides and polypeptides of the erythropoietin gene
11/27/2003WO2002081490A3 Computer-directed assembly of a polynucleotide encoding a target polypeptide
11/27/2003WO2002074964A3 Polypeptides derived from rna polymerases and use thereof
11/27/2003WO2002070006A8 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
11/27/2003WO2002068459A3 Non aggregating fluorescent proteins and methods for using the same
11/27/2003WO2002064791A3 Proteins and nucleic acids encoding same
11/27/2003WO2002063010A3 Method of producing recombinant antibodies against tumors
11/27/2003WO2002050113A3 Interleukin-1 related gene and protein
11/27/2003WO2002048368A3 Proteins associated with cell growth, differentiation, and death
11/27/2003US20030221209 Modified proteinase inhibitors
11/27/2003US20030220490 Cell membrane directed drugs
11/27/2003US20030220489 29 human secreted proteins
11/27/2003US20030220484 Modified ciliary neurotrophic factors
11/27/2003US20030220483 Comprises fibroblast growth factor homologous factor- 1 (FHF-1) for disgnosing, prevention and treatment of neurodegenerative or neoplastic disorders
1 ... 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 ... 1125